Currently, the mechanisms underlying the divergent histopathologies resulting from mutations in the same gene or protein domain, such as the formation of BC in certain individuals with MTOR or DEPDC5 mutations but not others, remain unclear. This evidence concerns the gene MTOR and breast cancer.